RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
In January 2023, the Indian Ministry of Health and Family Welfare wrote to seven state governments, from Himachal Pradesh in the far north of the country to Tamil Nadu in the far south, requesting them to start preparations for the roll-out of the human papillomavirus (HPV) vaccine for girls aged 9–14 years. The campaigns will represent the first of three phases in India's planned introduction of the HPV vaccine. Once the notified states have covered children aged 9–14 years, HPV vaccination will become part of their routine immunisation programmes. Similar efforts will follow in another set of states and union territories in 2024 and again in 2025. By the end, 68 million girls in India should have been vaccinated against HPV. A further 11·2 million girls aged 9 years will subsequently be targeted for routine HPV vaccination each year.
